GlassScriptPhysician profile
Andrew Rosenblatt
NPI 1932110012
$5,278.07
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,519 · 2020: $989 · 2021: $749 · 2022: $20.97.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $959.09 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $523.70 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $502.80 | 2019-2021 | |
| Chiesi USA, INC. | $470.38 | 2019-2021 | |
| Pfizer INC. | $374.23 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $367.63 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $277.30 | 2019-2021 | |
| Astellas Pharma US INC | $233.00 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $231.72 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $231.51 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $193.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $174.19 | 2019-2021 | |
| Irhythm Technologies, INC. | $163.05 | 2019-2020 | |
| Cathworks, INC. | $126.68 | 2019-2020 | |
| Boston Scientific Corporation | $122.20 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $117.47 | 2019-2021 | |
| Gilead Sciences, INC. | $66.72 | 2019 | |
| Alnylam Pharmaceuticals INC. | $43.06 | 2019 | |
| Lundbeck LLC | $42.91 | 2019 | |
| Heartflow, INC. | $23.83 | 2019 | |
| Bardy Diagnostics, INC. | $20.97 | 2022 | |
| Amarin Pharma, INC. | $12.47 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Rosenblatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.